SEOUL, May 30 (Xinhua) South Korean banks lending rate fell for the fifth consecutive month last month due to lower expectations for policy rate hikes, centr
Study demonstrates statistically significant and clinically relevant reduction in annualized bleeding rate compared to prophylaxis and on-demand intravenous regimens
Marstacimab, if approved, has. | May 30, 2023
Owing to the growing number of approvals of cell therapies, and a continuous rise in number of associated clinical trials, the demand for advanced cell therapy consumables is likely to witness
Achieved record revenues of $40 million for the first quarter Annualized revenue run rate of $159 million Adjusted EBITDA of $6 Million Strong balance sheet with over $45 million. | May 15, 2023